Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults

To determine how concomitant use of potentially interacting drugs, drug dosage, and duration of therapy modify the risk of hip fracture associated with use of benzodiazepines and benzodiazepine-related drugs (BDZ) in older adults.

Saved in:
Bibliographic Details
Main Authors: Zint, Kristina (Author) , Haefeli, Walter E. (Author) , Glynn, Robert J (Author) , Mogun, Helen (Author) , Avorn, Jerry (Author) , Stürmer, Til (Author)
Format: Article (Journal)
Language:English
Published: 7 October 2010
In: Pharmacoepidemiology and drug safety
Year: 2010, Volume: 19, Issue: 12, Pages: 1248-1255
ISSN:1099-1557
DOI:10.1002/pds.2031
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/pds.2031
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.2031
Get full text
Author Notes:Kristina Zint, Walter E. Haefeli, Robert J Glynn, Helen Mogun, Jerry Avorn and Til Stürmer
Description
Summary:To determine how concomitant use of potentially interacting drugs, drug dosage, and duration of therapy modify the risk of hip fracture associated with use of benzodiazepines and benzodiazepine-related drugs (BDZ) in older adults.
Item Description:Gesehen am 31.10.2023
Physical Description:Online Resource
ISSN:1099-1557
DOI:10.1002/pds.2031